Early research (Phase 1)Study completedNCT00904800What this trial is testingAZD0837 Extended Release (ER) Japan StudyWho this might be right forHealthy AstraZeneca 36
Early research (Phase 1)Study completedNCT01113021What this trial is testingStudy of Effects of Low Level Laser Therapy in the Physical Training and the Muscle Responses in Humans.Who this might be right forHealthy Young Male VolunteersNon AthletesFree of Metabolic Disease+1 more Universidade Federal de Sao Carlos
Early research (Phase 1)Ended earlyNCT01702350What this trial is testingA Four Part Study to Investigate Relative Bioavailability, Safety and Tolerability of up to 5 Oral Formulation of GSK2251052 in Order to Identify a Formulation for Further Evaluation in a Future Later Phase StudyWho this might be right forCommunity-acquired Infection GlaxoSmithKline 24
Early research (Phase 1)Study completedNCT02171234What this trial is testingA Double-blind, Randomised, Placebo-controlled, Rising Multiple Dose Study to Investigate the Safety, Tolerability, Steady State Pharmacokinetic Profile and CNS Effects of BIA 2-093Who this might be right forEpilepsy Bial - Portela C S.A. 32
Early research (Phase 1)Study completedNCT02199873What this trial is testingSafety, Tolerability and Pharmacodynamics of BIIX 1 XX in Healthy Young Male VolunteersWho this might be right forHealthy Boehringer Ingelheim 24
Early research (Phase 1)Study completedNCT02269215What this trial is testingSingle Increasing Doses of BIII 890 CL in Healthy Young Male Volunteers and in Healthy Elderly Male and Female VolunteersWho this might be right forHealthy Boehringer Ingelheim 73
Early research (Phase 1)Study completedNCT01285596What this trial is testingEvaluate How Mirabegron Enters and Leaves the Bloodstream According to Age and SexWho this might be right forHealthy VolunteersPharmacokinetics of Mirabegron Astellas Pharma Inc 75
Early research (Phase 1)Study completedNCT02199899What this trial is testingSafety, Tolerability and Pharmacodynamics of BIIF 1149 BS in Healthy Young Male VolunteersWho this might be right forHealthy Boehringer Ingelheim 64
Early research (Phase 1)Study completedNCT01461174What this trial is testingEffects of Donepezil and Memantine on Cognitive Functions After a Sleep Deprivation Challenge in Healthy VolunteersWho this might be right forHealthy Qualissima 36
Early research (Phase 1)Study completedNCT00354861What this trial is testingPhase I Study of a Hepatitis B Antigen Combined With IMP321Who this might be right forHealthy Immutep S.A.S. 48
Early research (Phase 1)Study completedNCT01611311What this trial is testingSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Rising Doses of BI 409306Who this might be right forHealthy Boehringer Ingelheim 40
Early research (Phase 1)Study completedNCT01148095What this trial is testingTo Investigate the Safety, Tolerability and Pharmacokinetics of AZD2516 After Multiple Dosing in Healthy VolunteersWho this might be right forPart A Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 Years.Part B Healthy Young Males and Non-fertile Female Volunteers Aged 20 to 45 and Elderly Volunteers Aged 60 to 80 AstraZeneca 6
Early research (Phase 1)Study completedNCT01054937What this trial is testingSingle Dose Study With 4SC-203 in Healthy VolunteersWho this might be right forAcute Myeloid Leukemia 4SC AG 60
Post-approval studies (Phase 4)Study completedNCT04137302What this trial is testingAdministration of Hydrocortisone in Young Healthy Male VolunteersWho this might be right forAnti-doping Campaign, Detection of Hydrocortisone Centre Hospitalier Régional d'Orléans 21
Early research (Phase 1)Study completedNCT01474161What this trial is testingComparative Bioavailability - Gender Effect - Single and Multiple Ascending Dose Safety and Pharmacokinetic Study of GFT505Who this might be right forType 2 DiabetesDiabetes Mellitus, Type 2Metabolic Diseases+3 more Genfit 96
Early research (Phase 1)Study completedNCT01505894What this trial is testingSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising DosesWho this might be right forHealthy Boehringer Ingelheim 83
Early research (Phase 1)Study completedNCT02010970What this trial is testingA Phase I Study in Healthy Volunteers to Assess the Effect of Cytochrome3A4 (CYP3A4) Inhibitors (Diltiazem and Itraconazole) on the Pharmacokinetics (PK) of AZD3293 and the Effects of AZD3293 on the Pharmacokinetics of Midazolam, a Cytochrome 3A4 and Cytochrome 3A5 (CYP3A4/CYP3A5) SubstrateWho this might be right forHealthy VolunteersPharmacologic Action AstraZeneca 56
Early research (Phase 1)Ended earlyNCT01647620What this trial is testingA Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses.Who this might be right forDeep Vein Thrombosis LegStroke (in Patients With Atrial Fibrillation) Diakron Pharmaceuticals 30
Early research (Phase 1)Study completedNCT02359344What this trial is testingPK & Tolerability of CNV1014802 in Young and Elderly Healthy VolunteersWho this might be right forTrigeminal Neuralgia Biogen 32
Early research (Phase 1)Study completedNCT02106247What this trial is testingSafety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of BI 1181181 in Healthy Male VolunteersWho this might be right forHealthy Boehringer Ingelheim 36